These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 31156795)
1. Association of rs712 polymorphism in a let-7 microRNA-binding site of Gallegos-Arreola MP; Zúñiga-González GM; Gómez-Mariscal K; Rosales-Reynoso MA; Luis L; Puebla-Pérez AM; Pineda-Razo T Iran J Basic Med Sci; 2019 Mar; 22(3):324-327. PubMed ID: 31156795 [TBL] [Abstract][Full Text] [Related]
2. Protective effect of rs712 polymorphism in a let-7 microRNA-binding of KRAS gene in breast cancer of a Mexican population. Patricia Gallegos-Arreola M; Briseño Zuno CJ; Eduardo Figuera L; Zúñiga González GM; Perales Mederos CI; Puebla Pérez AM; Rosales Reynoso MA J BUON; 2020; 25(1):176-181. PubMed ID: 32277629 [TBL] [Abstract][Full Text] [Related]
3. rs712 polymorphism within let-7 microRNA-binding site might be involved in the initiation and progression of colorectal cancer in Chinese population. Jiang QH; Peng HX; Zhang Y; Tian P; Xi ZL; Chen H Onco Targets Ther; 2015; 8():3041-5. PubMed ID: 26543374 [TBL] [Abstract][Full Text] [Related]
4. A let-7 KRAS rs712 polymorphism increases colorectal cancer risk. Pan XM; Sun RF; Li ZH; Guo XM; Zhang Z; Qin HJ; Xu GH; Gao LB Tumour Biol; 2014 Jan; 35(1):831-5. PubMed ID: 23975373 [TBL] [Abstract][Full Text] [Related]
5. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer. Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038 [TBL] [Abstract][Full Text] [Related]
6. A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer. Li ZH; Pan XM; Han BW; Guo XM; Zhang Z; Jia J; Gao LB Tumour Biol; 2013 Oct; 34(5):3159-63. PubMed ID: 23729275 [TBL] [Abstract][Full Text] [Related]
7. Significant association between Let-7-KRAS rs712 G > T polymorphism and cancer risk in the Chinese population: a meta-analysis. Du XY; Hu YY; Xie C; Deng CY; Liu CY; Luo ZG; Niu YM; Shen M Oncotarget; 2017 Feb; 8(8):13863-13871. PubMed ID: 28099923 [TBL] [Abstract][Full Text] [Related]
8. Association of rs712 polymorphism in Kras gene 3'-luntranslated region and cancer risk: a meta-analysis. Zhao WH; Qu XF; Xing ZG; Zhao LQ; Qin L; Lv C J BUON; 2015; 20(1):309-16. PubMed ID: 25778332 [TBL] [Abstract][Full Text] [Related]
9. A single nuclear polymorphism in let-7g binding site affects the doubling time of thyroid nodule by regulating KRAS-induced cell proliferation. Liu A; Zhang W; Zhao T; Xiao M; Mei Q; Zhu H J Cell Physiol; 2019 Dec; 234(12):23437-23447. PubMed ID: 31152438 [TBL] [Abstract][Full Text] [Related]
10. KRAS Gene Polymorphisms and their Impact on Breast Cancer Risk in an Iranian Population. Sanaei S; Hashemi M; Eskandari E; Hashemi SM; Bahari G Asian Pac J Cancer Prev; 2017 May; 18(5):1301-1305. PubMed ID: 28610418 [TBL] [Abstract][Full Text] [Related]
11. The involvement of Kras gene 3'-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis. Ying HQ; Wang F; He BS; Pan YQ; Gao TY; Xu YQ; Li R; Deng QW; Sun HL; Wang SK Onco Targets Ther; 2014; 7():1487-96. PubMed ID: 25210463 [TBL] [Abstract][Full Text] [Related]
12. Lack of association between let-7 binding site polymorphism rs712 and risk of nasopharyngeal carcinoma. Pan XM; Jia J; Guo XM; Li ZH; Zhang Z; Qin HJ; Xu GH; Gao LB Fam Cancer; 2014 Mar; 13(1):93-7. PubMed ID: 23996697 [TBL] [Abstract][Full Text] [Related]
13. Association between a functional polymorphism rs712 within let-7-binding site and risk of papillary thyroid cancer. Jin H; Liang Y; Wang X; Zhu J; Sun R; Chen P; Nie X; Gao L; Zhang L Med Oncol; 2014 Oct; 31(10):221. PubMed ID: 25201577 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis. Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575 [TBL] [Abstract][Full Text] [Related]
15. A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD. Hu H; Zhang L; Teng G; Wu Y; Chen Y Int J Chron Obstruct Pulmon Dis; 2015; 10():1641-9. PubMed ID: 26316738 [TBL] [Abstract][Full Text] [Related]
17. [Correlation between polymorphism in the promoter of DNA methyltransferase-3B and the risk of colorectal cancer]. Bao Q; He BS; Chen LP; Gu L; Nie ZL; Wang SK Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jan; 46(1):53-7. PubMed ID: 22490141 [TBL] [Abstract][Full Text] [Related]
18. Association between the Ning L; Rao W; Yu Y; Liu X; Pan Y; Ma Y; Liu R; Zhang S; Sun H; Yu Q J Cancer; 2016; 7(15):2420-2426. PubMed ID: 27994680 [TBL] [Abstract][Full Text] [Related]
19. Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival. Wang D; Liu Q; Ren Y; Zhang Y; Wang X; Liu B Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33825830 [TBL] [Abstract][Full Text] [Related]
20. The let-7 microRNA binding site variant in KRAS as a predictive biomarker for head and neck cancer patients with lymph node metastasis. Ulusan M; Sen S; Yilmazer R; Dalay N; Demokan S Pathol Res Pract; 2022 Nov; 239():154147. PubMed ID: 36228348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]